about
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver.Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1.Network analysis reveals potential markers for pediatric adrenocortical carcinomaDriver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cellsGene expression profiles and signaling mechanisms in α2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells.Inhibition of Cell Survival by Curcumin Is Associated with Downregulation of Cell Division Cycle 20 (Cdc20) in Pancreatic Cancer Cells.Sulfasalazine intensifies temozolomide cytotoxicity in human glioblastoma cells.Screening of biomarkers for prediction of response to and prognosis after chemotherapy for breast cancers.Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer.The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma.Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.The therapeutic potential of cell cycle targeting in multiple myeloma.Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.CDC20siRNA and paclitaxel co-loaded nanometric liposomes of a nipecotic acid-derived cationic amphiphile inhibit xenografted neuroblastoma.Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells.Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.Prognostic implications of securin expression and sub-cellular localization in human breast cancer.Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
P2860
Q33761920-00D718E8-0906-450B-B267-F5F9A9F7DE7CQ35782988-9D5922D0-987A-48A8-A7BC-EC0E5D02B650Q36196265-5F159A97-1FED-4F55-8823-E74746A0A456Q36751768-83C18A66-F69A-4592-B9C3-E3E2064D1930Q37143014-DCCF9609-98EB-47FF-ADEF-259B4843744AQ37269061-4E309B87-3546-480C-BCD8-83E84191C71BQ37688442-0693E78F-9776-422F-BC49-A4E708271087Q38698722-A950D94F-9647-46FE-A4B5-BDCB89561F7DQ38717782-5F8D03E6-1D3F-40F1-905D-0EA8A9E2ED2DQ38762744-605824E7-CFB0-4FA9-A29D-C8D05DCB9F2BQ39741084-EF43CEF8-6A71-4AC8-B8A8-D79B41AF2A60Q41168695-200E36DE-45FA-482E-B076-0C7DFDCD3E6EQ41789674-61F9168F-DC2A-4DB7-87F1-C38920243EC7Q41971182-BB903862-8390-45FC-89A3-771DAF766BA6Q47203904-CDBCFF4D-EF2C-44FF-927A-5E03C1B4E487Q47648800-3827FDFD-6C6E-4AFA-8314-3377BA518E2DQ48101540-40DFD37C-19A8-48BA-AB5B-8F7D9532AC98Q49584310-8321CE14-85AD-47E6-99A0-7586D4D760E6Q51363519-8234B732-F12D-4D4D-A364-CE7C5BD159FFQ52729889-E9294FEB-369E-4AD2-8F81-3113F1492FA8Q52880311-94FB7FC3-57DF-4979-8CA5-1FE316F2508AQ54977757-97CDDB3C-173D-4529-B6EF-7B3EC2CB5960Q58603880-9D913DB1-7DB4-46D1-A71E-DEED52AC1D9D
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting Cdc20 as a novel cancer therapeutic strategy.
@ast
Targeting Cdc20 as a novel cancer therapeutic strategy.
@en
type
label
Targeting Cdc20 as a novel cancer therapeutic strategy.
@ast
Targeting Cdc20 as a novel cancer therapeutic strategy.
@en
prefLabel
Targeting Cdc20 as a novel cancer therapeutic strategy.
@ast
Targeting Cdc20 as a novel cancer therapeutic strategy.
@en
P2093
P2860
P1476
Targeting Cdc20 as a novel cancer therapeutic strategy.
@en
P2093
Jinfang Zhang
Lixia Wang
Xiuxia Zhou
Zhiwei Wang
P2860
P304
P356
10.1016/J.PHARMTHERA.2015.04.002
P577
2015-04-04T00:00:00Z